For instance, inhibiting METTLE3 could induce dsRNA formation and trigger an IFN response, subsequently enhancing MHC-I antigen presentation and bolstering anti-tumor immunity (Guirguis et al., 2023). The gene discussed is IFNA1; the disease is neoplasm.